Between 2022 and 2027, the market for microbiology cultures is expected to grow at a CAGR of 7%. The market, which is currently valued at US$ 6.5 billion, is expected to grow to US$ 9.1 billion by the end of 2027. The microbiology culture market is the market for microorganism cultivation and identification products. This includes bacterial, fungal, and viral testing and identification media, reagents, instruments, and consumables used in microbiology labs.
The growing prevalence of infectious diseases, the growing demand for accurate and reliable diagnostic tests, and the development of new and advanced culture techniques are driving the market for microbiology culture products. Other market drivers include rising demand for food safety testing and the increased use of microbiology culture in drug development and production. The market is expected to expand further in the coming years, owing to technological advancements, the increasing prevalence of infectious diseases, and rising demand for food safety testing. However, the market faces a number of challenges, including regulatory constraints and the high cost of advanced culture techniques.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7763
Key Takeaways from Market Study
- The global microbiology culture market is valued at US$ 6.5 billion.
- Market in Canada is anticipated to magnify at a CAGR of 6.5% over the forecast period.
- The synthetic media segment is predicted to expand at a CAGR of 6% from 2022 to 2027.
- Market in Germany is set to increase at a CAGR of 4.6% through 2027.
Winning Strategy
As a result of factors like R&D spending, compliance with regulations, and technological advancements, new strategies are constantly being created. Cell division, biochemistry, and cell development can all be thoroughly studied using microbiology culture, which is frequently and primarily used for this purpose To meet the rising demand for microbiological culture, Merck Millipore plans to expand its operational capacity.
Key Companies Profiled:–
- BrightGene
- Cathay Biotech Inc.
- Neogen Corporation
- Scharlab, S.L.
- Sigma-Aldrich Corporation
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Eiken Chemical Co., Ltd.
- HiMedia Laboratories
- MilliporeSigma
- Neogen Corporation
- Vland Biotech
- Cabio Biotech
-
Thermo Fisher Scientific, Inc.
